RH
Insider
Richard A. Heyman
DirectorRichard A. Heyman (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Enliven Therapeutics, Inc. (ELVN). The largest single filing was $308K of ELVN (12,300 sh across 2 lots, as filed), executed Jan 8.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$308K
shares × price, as filed
Last traded
Jan 9
Filed Jan 12
Median ADV $83.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $308K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
ELVNRecent filings
ELVNSALE
Enliven Therapeutics, Inc.
View filing →
$308K12,300 sh across 2 lots
Exec Jan 8
Filed Jan 12 · 5:30 PM ET